85 related articles for article (PubMed ID: 5363860)
1. [Developing a clinical classification of systemic scleroderma].
Guseva NG
Vopr Revm; 1969; 9(2):14-8. PubMed ID: 5363860
[No Abstract] [Full Text] [Related]
2. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
[No Abstract] [Full Text] [Related]
3. [The evolution of the concepts of systemic scleroderma].
Guseva NG
Ter Arkh; 1995; 67(5):50-3. PubMed ID: 7638781
[No Abstract] [Full Text] [Related]
4. Preliminary criteria for the classification of systemic sclerosis (scleroderma).
Bull Rheum Dis; 1981; 31(1):1-6. PubMed ID: 7459513
[No Abstract] [Full Text] [Related]
5. Classification in systemic sclerosis.
Johnson SR; Laxer RM
J Rheumatol; 2006 May; 33(5):840-1. PubMed ID: 16652415
[No Abstract] [Full Text] [Related]
6. [Clinico-immunological characteristics of the course of systemic scleroderma].
Musaev SK; Speranskiĭ AI
Ter Arkh; 1984; 56(5):42-5. PubMed ID: 6611599
[No Abstract] [Full Text] [Related]
7. The development of systemic sclerosis (scleroderma) following augmentation mammoplasty.
Appleton BE; Lee P
J Rheumatol; 1993 Jun; 20(6):1052-4. PubMed ID: 8350312
[TBL] [Abstract][Full Text] [Related]
8. [Medical disability expertise in systemic scleroderma].
Shabel'nik VI; Tsyban' ME; Filiuk VF; Eliseĭkina LV; Lanchuk SG
Revmatologiia (Mosk); 1988; (2):23-6. PubMed ID: 3051271
[No Abstract] [Full Text] [Related]
9. [Some clinical variants of scleroderma].
Braĭtsev AV; Marzeeva GI
Vestn Dermatol Venerol; 1973 Aug; 47(8):19-24. PubMed ID: 4767948
[No Abstract] [Full Text] [Related]
10. [Clinical evaluation of the determination of blood serum and urinary glycosaminoglycans in systemic scleroderma].
Fuzaĭlov OR; Astakhova TA; Guseva NG
Ter Arkh; 1984; 56(5):45-9. PubMed ID: 6463886
[No Abstract] [Full Text] [Related]
11. [Characteristics of the clinical course of systemic scleroderma].
Iashchenko OB
Vrach Delo; 1984 Sep; (9):88-92. PubMed ID: 6506654
[No Abstract] [Full Text] [Related]
12. [Role of tryptophan metabolism in the pathogenesis of systemic scleroderma and pseudosclerodermic conditions].
Stachow A
Przegl Dermatol; 1979; 66(6):727-9. PubMed ID: 534291
[No Abstract] [Full Text] [Related]
13. [Collagen disease posing a difficult classification problem: scleroderma associated with Gougerot-Sjögren's syndrome].
Bouvier J; Michel PH; Cretin J
Bull Soc Fr Dermatol Syphiligr; 1968; 75(2):245-7. PubMed ID: 5677915
[No Abstract] [Full Text] [Related]
14. [Characteristics of clinical symptoms and course of systemic scleroderma depending on sex and age of onset].
Volkov AV; Starovoĭtova MN; Guseva NG
Ter Arkh; 2004; 76(5):7-11. PubMed ID: 15230123
[TBL] [Abstract][Full Text] [Related]
15. [Scleroderma. Etiopathogenetic and therapeutic considerations].
Carlesimo OA; Nini G; Santucci B
Minerva Dermatol; 1967 Jan; 42(1):1-11. PubMed ID: 5596505
[No Abstract] [Full Text] [Related]
16. [Role of blood vessels in the pathogenesis of diffuse scleroderma].
Kamiński A
Przegl Dermatol; 1974; 61(5):639-47. PubMed ID: 4278576
[No Abstract] [Full Text] [Related]
17. A proposal of criteria for the classification of systemic sclerosis.
Nadashkevich O; Davis P; Fritzler MJ
Med Sci Monit; 2004 Nov; 10(11):CR615-21. PubMed ID: 15507853
[TBL] [Abstract][Full Text] [Related]
18. [Transformation of scleroatrophic lichen into systemic scleroderma].
Grebennikov VA; Chalimova RA
Vestn Dermatol Venerol; 1983 Apr; (4):60-3. PubMed ID: 6882513
[No Abstract] [Full Text] [Related]
19. [Clinical significance of circulating immune complexes in systemic scleroderma].
Musaev SK; Speranskiĭ AI
Revmatologiia (Mosk); 1984; (2):48-50. PubMed ID: 6382544
[No Abstract] [Full Text] [Related]
20. [Scleroderma in children].
Beaudoing A; Bost M; Pont J; Dieterlen M
Pediatrie; 1971; 26(5):529-46. PubMed ID: 5565710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
